Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1,010.00p
   
  • Change Today:
    -90.00p
  • 52 Week High: 1,545.00p
  • 52 Week Low: 130.00p
  • Currency: UK Pounds
  • Shares Issued: 5.36m
  • Volume: 49,415
  • Market Cap: £54.15m
  • RiskGrade: 340
  • Beta: 0.03

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £1,896,043
Vladislav Sandler Ph.D. 103,862 £1,049,006
Peter Redmond 13,991 £141,309

Major Shareholders

Notifier** Holding Value*
Alexis Sandler 187,726 £1,896,033
David John Smith 143,594 £1,450,299
Dr Vladislav Sandler 103,862 £1,049,006
Optiva Securities Limited 70,329 £710,323
Flascherberg Capital Anstalt 69,991 £706,909
Craig Auringer 59,593 £601,889
HSBC Client Holdings Nominee (UK) Limited 45,160 £456,116
Ron Valk 42,828 £432,563
Samantha Bauer 42,706 £431,331
Plum Capital 29,232 £295,243
43 North LLC 28,429 £287,133
Abdelatif LACHAB 6,500 £65,650
Wayne Gibson 6,500 £65,650

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1,010.00p
Change Today -90.00p
% Change -8.18 %
52 Week High 1,545.00p
52 Week Low 130.00p
Volume 49,415
Shares Issued 5.36m
Market Cap £54.15m
Beta 0.03
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Price Trend
91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 14-Oct-2025

Time Volume / Share Price
15:04 9 @ 1,025.00p
14:55 4 @ 994.00p
16:59 980 @ 1,100.00p
15:46 1,422 @ 998.50p
16:35 1,045 @ 1,010.00p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page